- Transcenta Presented Two Scientific Posters at SITC 2022 Annual Meeting
- Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update
- Transcenta to Participate in Four Upcoming Conferences
- Transcenta To Present First-In-Class TST003 Antibody Program at the 10th TEMTIA Meeting
- Transcenta to Present Two Scientific Posters at SITC 2022 Annual Meeting
- Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting Antibody TST004 for the Treatment of IgA Nephropathy
- Transcenta Received IND Clearance from FDA for Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors
- Transcenta Releases Encouraging Interim Safety and Efficacy Data of the TST001 (Osemitamab) and Chemotherapy Combination Expansion Cohort for First Line Claudin18.2 Positive Gastric Cancer at ESMO Congress 2022
As of last trade,
Transcenta Holding Limited (6628:HKG.HZ) traded at 3.82, 80.19% above the 52 week low of 2.12 set on Aug 24, 2022.
2.12Aug 24 202210.20Jan 07 2022
Markit short selling activity
|Market cap||1.70bn HKD|
|EPS (TTM)||-2.28 |
Data delayed at least 15 minutes, as of Nov 25 2022.